KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Chuan-Chu Chou, Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles A. Lunn
Cited by 79
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272